Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$127.07 - $145.39 $53,369 - $61,063
-420 Reduced 20.23%
1,656 $220,000
Q1 2022

May 12, 2022

BUY
$129.09 - $164.35 $6,583 - $8,381
51 Added 2.52%
2,076 $284,000
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $16,983 - $20,934
121 Added 6.36%
2,025 $350,000
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $45,335 - $53,878
341 Added 21.82%
1,904 $277,000
Q2 2021

Aug 16, 2021

SELL
$126.66 - $141.48 $12,792 - $14,289
-101 Reduced 6.07%
1,563 $206,000
Q1 2021

May 17, 2021

SELL
$114.63 - $133.34 $102,364 - $119,072
-893 Reduced 34.92%
1,664 $214,000
Q4 2020

Feb 16, 2021

SELL
$112.7 - $128.05 $162,513 - $184,648
-1,442 Reduced 36.06%
2,557 $305 Million
Q3 2020

Nov 06, 2020

SELL
$107.05 - $130.01 $2.58 Million - $3.14 Million
-24,146 Reduced 85.79%
3,999 $457,000
Q2 2020

Aug 04, 2020

BUY
$73.34 - $122.61 $488,811 - $817,195
6,665 Added 31.03%
28,145 $3.21 Million
Q1 2020

May 12, 2020

SELL
$75.14 - $115.68 $228,425 - $351,667
-3,040 Reduced 12.4%
21,480 $1.73 Million
Q4 2019

Feb 04, 2020

SELL
$100.29 - $107.99 $532,038 - $572,886
-5,305 Reduced 17.79%
24,520 $2.62 Million
Q3 2019

Nov 07, 2019

SELL
$97.85 - $107.42 $603,832 - $662,888
-6,171 Reduced 17.14%
29,825 $3.19 Million
Q2 2019

Aug 05, 2019

SELL
$85.18 - $101.94 $379,476 - $454,142
-4,455 Reduced 11.01%
35,996 $3.67 Million
Q1 2019

May 08, 2019

BUY
$80.68 - $89.92 $991,879 - $1.11 Million
12,294 Added 43.66%
40,451 $3.64 Million
Q4 2018

Feb 12, 2019

SELL
$79.75 - $108.38 $372,193 - $505,809
-4,667 Reduced 14.22%
28,157 $2.34 Million
Q3 2018

Nov 13, 2018

BUY
$105.42 - $114.99 $3.46 Million - $3.77 Million
32,824 New
32,824 $3.54 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.